Total Payments
$242,134
2024 Payments
$10,011
Companies
26
Transactions
506
Medicare Patients
2,244
Medicare Billing
$264,779
Payment Breakdown by Category
Other$210,957 (87.1%)
Food & Beverage$12,252 (5.1%)
Consulting$11,231 (4.6%)
Travel$7,524 (3.1%)
Education$170.86 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $172,757 | 87 | 71.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $38,200 | 16 | 15.8% |
| Food and Beverage | $12,252 | 301 | 5.1% |
| Consulting Fee | $11,231 | 4 | 4.6% |
| Travel and Lodging | $7,524 | 90 | 3.1% |
| Education | $170.86 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $127,221 | 196 | $0 (2024) |
| PFIZER INC. | $42,283 | 79 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $26,958 | 55 | $0 (2021) |
| Synergy Pharmaceuticals Inc | $24,970 | 60 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $16,664 | 23 | $0 (2017) |
| Dova Pharmaceuticals | $1,799 | 4 | $0 (2018) |
| Amgen Inc. | $439.50 | 24 | $0 (2021) |
| Shire North American Group Inc | $246.24 | 2 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $220.36 | 6 | $0 (2022) |
| Allergan Inc. | $200.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,011 | 13 | ABBVIE INC. ($9,990) |
| 2023 | $10,660 | 26 | ABBVIE INC. ($10,451) |
| 2022 | $21,502 | 24 | ABBVIE INC. ($21,415) |
| 2021 | $12,855 | 35 | AbbVie Inc. ($12,497) |
| 2020 | $5,959 | 34 | AbbVie Inc. ($5,108) |
| 2019 | $65,423 | 123 | PFIZER INC. ($28,364) |
| 2018 | $62,892 | 146 | AbbVie, Inc. ($24,011) |
| 2017 | $52,831 | 105 | AbbVie, Inc. ($21,318) |
All Payment Transactions
506 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $32.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $30.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.97 | General |
| Category: IMMUNOLOGY | ||||||
| 04/29/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/25/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.46 | General |
| Category: THERAPY FOR CSID | ||||||
| 01/05/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/15/2023 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2023 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: IMMUNOLOGY | ||||||
| 08/31/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.07 | General |
| Category: GI | ||||||
| 08/31/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $10.67 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/10/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $16.10 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/05/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $8.53 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/05/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $19.43 | General |
| Category: THERAPY FOR CSID | ||||||
| 05/18/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $17.91 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 443 | 780 | $189,870 | $56,169 |
| 2022 | 9 | 505 | 939 | $211,891 | $62,562 |
| 2021 | 10 | 574 | 1,004 | $237,414 | $76,946 |
| 2020 | 12 | 722 | 1,127 | $221,058 | $69,101 |
Total Patients
2,244
Total Services
3,850
Medicare Billing
$264,779
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 226 | 534 | $72,090 | $32,637 | 45.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 86 | $15,050 | $6,178 | 41.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 36 | 36 | $29,700 | $5,608 | 18.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 60 | 65 | $42,250 | $5,442 | 12.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $5,100 | $2,414 | 47.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 11 | 17 | $14,450 | $1,967 | 13.6% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 11 | 11 | $9,900 | $1,547 | 15.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 14 | $1,330 | $377.30 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 233 | 617 | $83,295 | $38,132 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 102 | $17,850 | $7,673 | 43.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 68 | 74 | $48,100 | $5,682 | 11.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 31 | 31 | $25,575 | $4,312 | 16.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 17 | 24 | $20,400 | $2,988 | 14.6% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 14 | 14 | $12,600 | $2,100 | 16.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 29 | 35 | $3,325 | $1,022 | 30.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 21 | $735.00 | $642.81 | 87.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 21 | 21 | $10.50 | $10.29 | 98.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 261 | 620 | $81,379 | $40,942 | 50.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 86 | 94 | $61,100 | $7,751 | 12.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 76 | $13,210 | $5,644 | 42.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 38 | 54 | $9,450 | $5,474 | 57.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 31 | 31 | $25,575 | $5,035 | 19.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 28 | 45 | $5,675 | $3,132 | 55.2% |
| 45384 | Removal of tissue abnormalities, tumors, or polyps of large bowel by hot biopsy forceps, using a flexible endoscope | Facility | 2021 | 20 | 20 | $18,000 | $3,090 | 17.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 20 | 20 | $6,000 | $2,942 | 49.0% |
About Dr. Joseph Lowney, D.O
Dr. Joseph Lowney, D.O is a Gastroenterology healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710983416.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Lowney, D.O has received a total of $242,134 in payments from pharmaceutical and medical device companies, with $10,011 received in 2024. These payments were reported across 506 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($172,757).
As a Medicare-enrolled provider, Lowney has provided services to 2,244 Medicare beneficiaries, totaling 3,850 services with total Medicare billing of $264,779. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Warwick, RI
- Active Since 06/27/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1710983416
Products in Payments
- Humira (Biological) $50,991
- XELJANZ (Drug) $41,743
- Trulance (Drug) $24,970
- SKYRIZI (Biological) $18,956
- RINVOQ (Biological) $17,870
- HUMIRA (Biological) $15,435
- XIFAXAN (Drug) $14,829
- APRISO (Drug) $10,222
- TRULANCE (Drug) $10,112
- RELISTOR (Drug) $6,326
- UCERIS (Drug) $2,108
- Doptelet (Drug) $1,799
- LINZESS (Drug) $266.15
- EVENITY (Biological) $191.03
- Prolia (Biological) $179.34
- ORENCIA (Biological) $169.35
- Sucraid (Drug) $146.16
- Entyvio (Biological) $134.00
- Ozanimod (Drug) $122.77
- Mitigare (Drug) $119.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Warwick
Dr. Mohamed Azzouz, M.d, M.D
Gastroenterology — Payments: $4,416
Gastroenterology $4,416
Dr. Jameel Shareef, Do, DO
Gastroenterology — Payments: $2,630
Gastroenterology $2,630
Sulman Khan
Gastroenterology — Payments: $488.99
Gastroenterology $488.99
Timothy Graziano
Gastroenterology — Payments: $48.04
Gastroenterology $48.04
Jennette Butterfield, Npp, NPP
Gastroenterology
Gastroenterology
Mr. Antoine Hadamard, Md, MD
Gastroenterology
Gastroenterology